Target intelligence / Profile preview

Poly-L-lysine (PLL)

Target
PLL
Molecular classification
Polypeptide, Cationic polymer
01

Overview

Poly-L-lysine (PLL) is a synthetic cationic homopolypeptide consisting of repeating units of the essential amino acid L-lysine [PubChem]. It is primarily recognized for its ability to mediate strong electrostatic interactions with negatively charged molecules and surfaces, such as the phosphate backbone of DNA or the glycocalyx of cell membranes [ScienceDirect]. In biomedical research, PLL is extensively used as a coating for glass and plastic cultureware to promote cell attachment and spreading [Sigma-Aldrich]. Beyond its role as a laboratory reagent, PLL serves as a versatile scaffold for drug and gene delivery systems, forming 'polyplexes' that protect nucleic acids from enzymatic degradation and facilitate their cellular uptake [PubMed]. It also possesses intrinsic antimicrobial properties, particularly against Gram-positive and Gram-negative bacteria, by disrupting the integrity of the bacterial cell wall through charge-based interactions [NIH]. However, the clinical utility of PLL is often limited by its molecular weight-dependent cytotoxicity and potential to induce hemolysis or systemic inflammatory responses [Journal of Controlled Release].

Other names
Poly(L-lysine)alpha-Poly-L-lysinePLLPoly-L-lysine hydrobromide
02

Mechanism of action

Poly-L-lysine acts via electrostatic attraction between its positively charged epsilon-amino groups and negatively charged biological components, such as the phosphate backbone of nucleic acids or the glycocalyx of cell membranes [ScienceDirect, NIH].

03

Biological functions

Cell adhesionAntimicrobial activityNucleic acid bindingMembrane disruption
04

Disease associations

Bacterial infectionCancerGenetic disorders
05

Safety considerations

CytotoxicityHemolysisImmunogenicityInflammatory response
06

Interacting drugs

Heparin

2 more in the full profile.

Beyond the preview

Go deeper on Poly-L-lysine (PLL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly-L-lysine (PLL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call